Ligand Pharmaceuticals (LGND) Non Operating Investment Income (2015 - 2026)
Ligand Pharmaceuticals (LGND) reported Non Operating Investment Income of $11.75 million for Q2 2026, compared with $939,000 a year earlier and up 203.8% from the prior quarter.
Powered by 
Analysis
Ligand Pharmaceuticals (LGND) Non Operating Investment Income (2015 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Ligand Pharmaceuticals' Non Operating Investment Income came in at $45.48 million; for FY2025, it was $18.43 million, down 75.4% from FY2024.
- By year, Non Operating Investment Income came in at $75.02 million in FY2024 (+61.8%), $46.37 million in FY2023 (+62.5%), $28.54 million in FY2022 and -$5.26 million in FY2021.
- Five-year quarterly Non Operating Investment Income spans a low of -$23.9 million in Q4 2024 and a high of $110.77 million in Q1 2024.
- Per Business Quant data, the three quarters before Q2 2026 came in at $3.87 million (Q1 2026), $22.06 million (Q4 2025) and $7.8 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Op. Investment Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Ligand Pharmaceuticals | 6.03 Bn | 2.50 Bn | - | 11.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.75 Mn |
| Mar 31, 2026 | 3.87 Mn |
| Dec 31, 2025 | 22.06 Mn |
| Sep 30, 2025 | 7.80 Mn |
| Jun 30, 2025 | 939,000.00 |
| Mar 31, 2025 | -12.37 Mn |
| Dec 31, 2024 | -23.90 Mn |
| Sep 30, 2024 | 2.41 Mn |
| Jun 30, 2024 | -14.26 Mn |
| Mar 31, 2024 | 110.77 Mn |
| Dec 31, 2023 | 16.03 Mn |
| Sep 30, 2023 | -13.18 Mn |
| Jun 30, 2023 | 3.99 Mn |
| Mar 31, 2023 | 39.53 Mn |
| Dec 31, 2022 | 44.25 Mn |
| Sep 30, 2022 | -923,000.00 |
| Jun 30, 2022 | -1.91 Mn |
| Mar 31, 2022 | -12.88 Mn |
| Dec 31, 2021 | -13.40 Mn |
| Sep 30, 2021 | 1.94 Mn |
API Access
Ligand Pharmaceuticals Non Operating Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=LGND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-investment-income", "ticker": "LGND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=LGND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();